3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
10
Obesity
3
Neoplasms
3
Sarcopenia
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Colorectal Neoplasms
2
Wound Infection
1
Weight Loss
1
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Overweight
1
Osteoarthritis
1
Olfaction Disorders
1
Non-alcoholic Fatty Liver Disease
1
Neuroma, Acoustic
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mandibular Neoplasms
1
Interventions
Radiosurgery
6
Bevacizumab
4
Gentamicins
3
Everolimus
3
Cochlear Implants
3
Lapatinib
2
tozuleristide
1
neratinib
1
icotinib
1
gallium Ga 68 dotatate
1
brigatinib
1
Triamcinolone Acetonide
1
Sufentanil
1
Sirolimus
1
Microsurgery
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Head Movements
1
HDAC-42
1
Fluoresceins
1
Fluorescein
1
Exome
1
Endostatins
1
Endoscopes
1
Docosahexaenoic Acids
1
Decision Support Techniques
1
Axitinib
1
Aspirin
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroma, Acoustic
×
Docosahexaenoic Acids
×
Clear all
NCT05116878
2023-09-08
EFFORTS
Mayo Clinic
Phase NA
Terminated
15 enrolled